Skip to content
Screener

Silicon Laboratories SLAB Business Segments — Other research and development expenses

Similar metrics at other companies

Veracyte logo
VCYTReportable Segment — Other research and development expenses
$5.46M+201%
Roivant Sciences logo
ROIVReportable Segment — Other research and development expenses
$7.86M-18.4%
Inhibrx Biosciences, Inc. logo
INBXReportable Segment — Other Research and Development Expense
$2.91M-7.8%
Archer Aviation logo
ACHRReportable Segment — Other research and development expense
$133.3M+51.1%
Crinetics Pharmaceuticals logo
CRNXReportable Segment — Other Research and Development Expense
$8.3M+23.2%
Arvinas logo
ARVNReportable Segment — Other research and development expense
$2.4M-22.6%

Other financials

Income statement

See full
Revenue$213.5M+20.1%
Gross profit$127.0M+29.9%
Operating income-$17.1M+46.8%
Net income-$15.9M+47.8%
EPS (diluted)-$0.48+48.9%

Balance sheet

See full
Cash & equivalents$383.1M+17.9%
Total debt$24.0M+11.8%
Total equity$1.1B+2.8%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$4.9M-89.7%
CapEx$9.8M+103%
Free cash flow-$4.9M-111%

Valuation

See full
Market cap$7.2B+77.2%
P/S8.8×+3.0×

Profitability

See full
Gross margin59.3%+5.1pp
Operating margin-6.8%-2.7pp
Net margin-6.1%-2.6pp
FCF margin-6.3%-21.8pp

Returns & leverage

See full
Return on equity-4.6%-1.9pp
Debt / equity0.0×
Current ratio5.1×-0.1×

Where this comes from

Reported directly by Silicon Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherResearchAndDevelopmentExpense.

The source filing: Silicon Laboratories’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001038074-26-000020
Line itemThree Months Ended / April 4,2026Three Months Ended / April 5,2025
Research and development:
Employee base compensation$32,316$32,972
Other research and development expenses (1)56,27855,247
Total research and development$88,594$88,219
Selling, general and administrative:
Employee base compensation$13,775$14,107
Other selling, general and administrative expenses (1)41,71127,531
Total selling, general and administrative$55,486$41,638

Item 1. Financial Statements (Unaudited):

FAQ

What is Silicon Laboratories's business segments — other research and development expenses?
Silicon Laboratories (SLAB) reported business segments — other research and development expenses of $56.28M in Q1 2026.
How has Silicon Laboratories's business segments — other research and development expenses changed year-over-year?
Silicon Laboratories's business segments — other research and development expenses increased by 1.9% year-over-year, from $55.25M to $56.28M.
What is the long-term trend for Silicon Laboratories's business segments — other research and development expenses?
Over 2 years (2023 to 2025), Silicon Laboratories's business segments — other research and development expenses has grown at a 2.2% compound annual growth rate (CAGR), from $212.89M to $222.27M.
What does business segments — other research and development expenses mean?
This metric captures research and development expenditures within the segment that are not classified as direct employee base compensation. It typically includes costs for materials, prototypes, third-party testing, and specialized equipment necessary for product innovation.

Ask your AI about Silicon Laboratories's business segments — other research and development expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude